Meeting
2012 Genitourinary Cancers Symposium
The influence of daily localization during treatment of prostate cancer on acute toxicity.
Authors
Peter john Rossi
Winship Cancer Institute of Emory University School of Medicine, Atlanta, GA
Peter john Rossi , Sherrie Cooper , Ashesh B. Jani
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 30, 2012 (suppl 5; abstr 214)
DOI
10.1200/jco.2012.30.5_suppl.214
Abstract #
214
Poster Bd #
C15
Abstract Disclosures
Similar Posters
Poster
2013 Genitourinary Cancers Symposium
A pilot study of high-dose exisulind in men with biochemical relapse (BCR) of prostate cancer after definitive local therapy treated with intermittent androgen deprivation (IAD).
First Author: Evan Y. Yu
Poster
2024 ASCO Genitourinary Cancers Symposium
Systemic and tumor-directed therapy for oligometastatic prostate cancer (SOLAR): A phase II trial for veterans with de novo oligometastatic prostate cancer.
First Author: Nicholas George Nickols
Poster
2024 ASCO Genitourinary Cancers Symposium
Days spent with healthcare contact by patients with metastatic castrate-resistant prostate cancer in the last year of life.
First Author: Daniel Sentana Lledo
Poster
2024 ASCO Genitourinary Cancers Symposium
Real world outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with lutetium-177-PSMA-vipivotide tetraxetan (Lu177-PVT).
First Author: Colin P Bergstrom